Fisher & Paykel Healthcare reports a 24% rise in profit
New Zealand-based medical device maker Fisher & Paykel Healthcare reported a 24% rise in annual profit. Demand for respiratory and hospital-care products supported the growth. The results point to a strong performance for one of the country's leading listed companies.
According to RNZ Business, New Zealand-based medical device maker Fisher & Paykel Healthcare reported a 24% rise in annual profit. The company is among the country's largest listed firms on the stock exchange.
Demand for respiratory devices and hospital-care products contributed to the growth. The company's globally sold product range allows revenue to be spread across different markets.
The strong profit increase points to resilient demand in the medical device sector. This content is not investment advice; the company's performance in the period ahead will depend on exchange rates, production costs and the trend in healthcare spending.
More from Australia-Pacific
Aspiration has changed since the Howard era. This budget is finally catching up
Treasurer Jim Chalmers's 2026-27 budget proposes a sweeping reorientation of housing, childcare and education incentives. According to ABC analysis, the budget breaks with the middle-class identity of the John Howard era and refocuses on a younger generation of renting voters.
Australia sets up fight with Santos over gas reservation plan
The Australian government's draft framework would require gas producers to supply 20% of their exports to the domestic market. The gas lobby argues the rule will 'undermine' the industry. The plan sets up a tension between local supply security and the sector's export interests.
Will drastic NDIS overhaul repeat the mistakes of the past?
Australia's planned overhaul of the National Disability Insurance Scheme is raising fears that the cuts could repeat the mistakes of the 1980s deinstitutionalisation wave. Advocates and health experts warn sudden changes could leave a serious care gap.